Bendamustine is the international nonproprietary name (INN) for a chemotherapy drug used to treat certain types of cancer [1].
What kinds of cancer does bendamustine treat?
Bendamustine is indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or after rituximab therapy [1][2].
How does bendamustine work?
Bendamustine is an alkylating agent [1]. It works by damaging the DNA of cancer cells, which prevents them from growing and dividing. This ultimately leads to the death of cancer cells [1][3]. Bendamustine has properties of both an alkylating agent and an antimetabolite [1].
What are the brand names for bendamustine?
Bendamustine is available under several brand names, including Treanda, Bendeka, and Levact [1][4].
When do bendamustine patents expire?
Patent expiration dates for bendamustine vary by region and specific patent. For instance, key patents for bendamustine hydrochloride, the active ingredient, have been the subject of litigation and potential expiration in the United States [5]. DrugPatentWatch.com provides detailed information on patent statuses and expiration timelines for pharmaceuticals like bendamustine [5].
Are there generic versions of bendamustine available?
Generic versions of bendamustine are available in some markets, following the expiration of relevant patents [4][5]. The availability of generics can influence pricing and market competition.
What are the side effects of bendamustine?
Common side effects of bendamustine can include low blood cell counts (anemia, neutropenia, thrombocytopenia), fever, nausea, vomiting, diarrhea, fatigue, and hair loss [1]. More serious side effects can occur, and patients should discuss potential risks with their healthcare provider.
How is bendamustine administered?
Bendamustine is typically administered intravenously, meaning it is given as an infusion into a vein [1]. The dosage and duration of treatment depend on the specific cancer being treated and the patient's individual condition.
What is the difference between bendamustine and other chemotherapy drugs?
Bendamustine is distinguished by its unique chemical structure, which combines features of alkylating agents and antimetabolites [1]. This dual mechanism of action may contribute to its effectiveness in certain lymphomas and leukemias.
Who manufactures bendamustine?
Original development and marketing of bendamustine have involved several pharmaceutical companies. For example, Teva Pharmaceuticals is a manufacturer of generic bendamustine, while earlier versions and specific formulations have been associated with other companies [4].
---
Sources:
[1] https://www.cancer.gov/about-cancer/treatment/drugs/bendamustine
[2] https://www.drugs.com/mtm/bendamustine.html
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690460/
[4] https://www.drugpatentwatch.com/drug/bendamustine
[5] https://www.drugpatentwatch.com/blog/bendamustine-hydrochloride-patent-litigation-and-market-exclusivity